Medical Facilities New Stock Current Valuation
31F Stock | EUR 10.40 0.10 0.95% |
Valuation analysis of MEDICAL FACILITIES NEW helps investors to measure MEDICAL FACILITIES's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that MEDICAL FACILITIES's price fluctuation is somewhat reliable at this time. Calculation of the real value of MEDICAL FACILITIES NEW is based on 3 months time horizon. Increasing MEDICAL FACILITIES's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MEDICAL stock is determined by what a typical buyer is willing to pay for full or partial control of MEDICAL FACILITIES NEW. Since MEDICAL FACILITIES is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MEDICAL Stock. However, MEDICAL FACILITIES's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 10.4 | Real 8.47 | Hype 10.4 | Naive 10.89 |
The real value of MEDICAL Stock, also known as its intrinsic value, is the underlying worth of MEDICAL FACILITIES NEW Company, which is reflected in its stock price. It is based on MEDICAL FACILITIES's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MEDICAL FACILITIES's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MEDICAL FACILITIES NEW helps investors to forecast how MEDICAL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MEDICAL FACILITIES more accurately as focusing exclusively on MEDICAL FACILITIES's fundamentals will not take into account other important factors: MEDICAL FACILITIES NEW Company Current Valuation Analysis
MEDICAL FACILITIES's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, MEDICAL FACILITIES NEW has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Care industry. The current valuation for all Germany stocks is 100.0% higher than that of the company.
MEDICAL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEDICAL FACILITIES's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEDICAL FACILITIES could also be used in its relative valuation, which is a method of valuing MEDICAL FACILITIES by comparing valuation metrics of similar companies.MEDICAL FACILITIES is currently under evaluation in current valuation category among its peers.
MEDICAL Fundamentals
Return On Equity | 0.22 | |||
Return On Asset | 0.0875 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.14 % | |||
Shares Outstanding | 26.15 M | |||
Shares Owned By Insiders | 0.48 % | |||
Shares Owned By Institutions | 18.77 % | |||
Price To Earning | 48.81 X | |||
Revenue | 415.79 M | |||
Gross Profit | 148.71 M | |||
EBITDA | 70.57 M | |||
Net Income | 6.41 M | |||
Cash And Equivalents | 46.52 M | |||
Cash Per Share | 1.50 X | |||
Total Debt | 233.27 M | |||
Debt To Equity | 132.10 % | |||
Current Ratio | 1.14 X | |||
Book Value Per Share | 3.96 X | |||
Cash Flow From Operations | 79.96 M | |||
Earnings Per Share | 0.24 X | |||
Number Of Employees | 12 | |||
Beta | 0.72 | |||
Market Capitalization | 146.54 M | |||
Annual Yield | 0.04 % | |||
Last Dividend Paid | 0.24 |
About MEDICAL FACILITIES Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDICAL FACILITIES NEW's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDICAL FACILITIES using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDICAL FACILITIES NEW based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in MEDICAL Stock
MEDICAL FACILITIES financial ratios help investors to determine whether MEDICAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDICAL with respect to the benefits of owning MEDICAL FACILITIES security.